Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...
The Purdy family is working with researchers to develop an entirely new clinical trial they hope will save Paxton and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback